Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short sequential oral therapy vs standard intravenous therapy for uncomplicated catheter-related Staphylococcus aureus bacteremia (MSSA)
2013-000511-24Phase 3Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Mar 2013
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in catheter-associated bloodstream infection (CRBSI) comparing Standard intravenous cloxacillin with Sequential IV cloxacillin then oral levofloxacin (2 arms). Primary endpoint: Late complications rate of catheter-related MSSA bacteremia. Started Mar 2013; status: completed.
02
Drugs
cloxacillinlevofloxacin
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on 2013-000511-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000511-24.